Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
Clinical trial NCT03450967 · UNKNOWN
Trial details
- NCT number
- NCT03450967
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-11
- Primary completion
- 2021-06-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.